Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
07/15/2009 | EP2078756A1 Detection of bacterium by utilizing dnaj gene and use thereof |
07/15/2009 | EP2078754A2 GRG23 and GRG51 genes conferring herbicide resistance |
07/15/2009 | EP2078753A2 Cell proliferation-related polypeptides and uses therefor |
07/15/2009 | EP2078752A2 ALK-1 responds to TGF-beta and signals through SMAD-1 and SMAD-5 |
07/15/2009 | EP2078751A1 Specific aptamers generated for suppression of cell migration and invasion by cancer cells, methods of selection for such aptamers and their usage |
07/15/2009 | EP2078750A1 A fluorescent two-hybrid (F2H) assay for direct visualization of protein interactions in living cells |
07/15/2009 | EP2078749A1 Method of evaluating drug sensitivity by analyzing the mu-opioid receptor gene |
07/15/2009 | EP2078748A1 Novel highly active modified type s-hydroxynitrile lyase |
07/15/2009 | EP2078747A1 Primer set for amplification of nat2 gene, reagent for amplification of nat2 gene comprising the same, and use of the same |
07/15/2009 | EP2078746A1 Metarhizium anisopliae var. dcjhyium and uses thereof |
07/15/2009 | EP2078732A1 Method of classifying antigen, method of identifying antigen, method of obtaining antibody or antibody set, method of constructing antibody panel and antibody or antibody set and use of the same |
07/15/2009 | EP2078731A1 Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient |
07/15/2009 | EP2078726A1 Secretable HIV entry inhibitory peptides for therapy of HIV infection |
07/15/2009 | EP2078531A2 Pharmaceutical compositions and methods useful for modulating angiogenesis |
07/15/2009 | EP2078455A1 Plant cell having animal-type sugar chain adding function |
07/15/2009 | EP2078198A2 Use of cell surface displays in yeast cell catalyst supports |
07/15/2009 | EP2078090A2 Plants having enhanced yield-related traits and a method for making the same |
07/15/2009 | EP2078089A2 Soybean event dp-305423-1 and compositions and methods for the identification and/or detection thereof |
07/15/2009 | EP2078088A2 Improvement of the kernel productivity of plants through the modulation of glutamine synthetase activity |
07/15/2009 | EP2078087A1 Method for increasing pathogen resistance in transgenic plants |
07/15/2009 | EP2078086A1 Immunogenic affinity-conjugated antigen systems based on papaya mosaic virus and uses thereof |
07/15/2009 | EP2078085A1 Alleles of the prpd1-gene from coryneform bacteria |
07/15/2009 | EP2078084A1 Glucanotransferase |
07/15/2009 | EP2078082A1 Recombinant human interferon-like proteins |
07/15/2009 | EP2078081A2 Identification of bitter ligands that specifically activate human t2r receptors and related assays for identifying human bitter taste modulators |
07/15/2009 | EP2078080A2 Cpg oligonucleotide analogs containing hydrophobic t analogs with enhanced immunostimulatory activity |
07/15/2009 | EP2078079A2 Adipocyte-specific constructs and methods for inhibiting platelet-type 12 lipoxygenase expression |
07/15/2009 | EP2078078A1 Selection of well-expressed synthetic genes |
07/15/2009 | EP2078077A2 Nucleic acid libraries and their design and assembly |
07/15/2009 | EP2078076A2 ENHANCED EXPRESSION FROM THE Pm PROMOTER |
07/15/2009 | EP2078075A2 Random homozygous gene perturbation to enhance antibody production |
07/15/2009 | EP2078041A2 Fusion proteins comprising two or more igg binding domains of streptococcal protein g. |
07/15/2009 | EP2077862A2 Pathotropic targeted gene delivery system for cancer and other disorders |
07/15/2009 | EP2006305A9 Modified antibody with enhanced bioactivity |
07/15/2009 | EP1996939A4 Compositions and methods for reducing cellular fat and for predicting cardiac toxicity and upon treatment with tyrosine kinase inhibitors |
07/15/2009 | EP1987142A4 Esterases and related nucleic acids and methods |
07/15/2009 | EP1865969A4 Ultra low strength electric field network-mediated ex vivo gene, protein and drug delivery in cells |
07/15/2009 | EP1856256B1 Free reactant use in nucleic acid-templated synthesis |
07/15/2009 | EP1805312B1 Methods and means for producing hyaluronan |
07/15/2009 | EP1653989B1 Anti-bacterial composition, especially for controlling gram-negative bacteria, comprising a peptide and an advantageously hydrophobic anti-bacterial agent |
07/15/2009 | EP1651668B1 Novel peptide interacting with anti-apoptotic proteins of a bcl-2 family |
07/15/2009 | EP1628681A4 Method of reducing the harmful effects of orally or transdermally delivered nicotine |
07/15/2009 | EP1614745B1 Process for producing glucose dehydrogenase |
07/15/2009 | EP1604025B1 Texturizing lactic bacteria |
07/15/2009 | EP1558635B1 Vaccine |
07/15/2009 | EP1517989B1 Method for the diagnosing of sphingolipid metabolism |
07/15/2009 | EP1507561B1 Compositions for delivering nucleic acids to cells |
07/15/2009 | EP1470422B1 Solid phases optimized for chemiluminescent detection |
07/15/2009 | EP1461625B1 Resistance circuit stabilization system for electroporation instruments |
07/15/2009 | EP1395278B1 Ocular tear growth factor-like protein |
07/15/2009 | EP1385976B1 Methods for the reduction of stutter in microsatellite amplification using sorbitol |
07/15/2009 | EP1268837B1 Method of generating transgenic mammals using transposons |
07/15/2009 | EP1268802B1 Beta-like glycoprotein hormone polypeptide and heterodimer |
07/15/2009 | EP1265712B1 Heating specimen carriers |
07/15/2009 | EP1214097B1 Nucleic acids encoding polyepitope polypeptides |
07/15/2009 | EP1200553B1 Metabolic engineering of amino acid production |
07/15/2009 | EP1144429B1 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders |
07/15/2009 | EP1141015B1 Insulin-like growth factor (igf) i mutant variants |
07/15/2009 | EP1115862B1 Cytokine receptor zalpha11 |
07/15/2009 | CN101484588A Compositions and methods for inhibiting expression of the PCSK9 gene |
07/15/2009 | CN101484583A Oncolytic adenoviruses for the treatment of cancer |
07/15/2009 | CN101484582A Transplastomic plants expressing lumen-targeted protein |
07/15/2009 | CN101484581A Plant artificial chromosome platforms via telomere truncation |
07/15/2009 | CN101484580A Cosmid vector for plant transformation and use thereof |
07/15/2009 | CN101484579A High-affinity antagonists of ELR-CXC chemokines |
07/15/2009 | CN101484578A Short interfering rna duplexes targeting an ires sequence and uses therefor |
07/15/2009 | CN101481709A Method for transforming bacillus |
07/15/2009 | CN101481708A Lentivirus-thymidine kinase gene configuration, and acquiring process and clinical application thereof |
07/15/2009 | CN101481707A Construction of tissue specific eucaryon expression vector pIE and use in HLA-DR transgenic technology |
07/15/2009 | CN101481706A Recombinant plasmid containing MDR1 gene promoter and reporter gene and uses thereof |
07/15/2009 | CN101481705A Human insulin-like growth factor conjugated protein 3 eucaryon expression vector, construction and use |
07/15/2009 | CN101481704A Tetracycline stringent controlled eucaryon expression vector |
07/15/2009 | CN101481703A Avian origin promoter expression vector, construction method and use thereof |
07/15/2009 | CN101481702A Recombinant vector containing polyhedrosis gene, and method for expressing and purifying protein |
07/15/2009 | CN101481701A Preparation of phycoerythrocyanin fluorescent protein combined with phycoerythrobilin |
07/15/2009 | CN101481700A Preparation of phycoerythrocyanin fluorescent protein combined with phycoerythrobilin |
07/15/2009 | CN101481699A Preparation of streptavidin labeled allophycocyanin fluorescent protein combined with phycoerythrobilin |
07/15/2009 | CN101481698A Preparation of allophycocyanin fluorescent protein combined with phycoerythrobilin |
07/15/2009 | CN101481697A Preparation of streptavidin labeled phycocyanin fluorescent protein combined with phycoerythrobilin |
07/15/2009 | CN101481696A Cold adapted endo beta-xylanase gene XynA and use |
07/15/2009 | CN101481695A Improved Rhizomucor miehei lipase gene and use thereof in yeast display |
07/15/2009 | CN101481694A Gentiana straminea beta-amyrin synthetase gene GsAS2 and use thereof |
07/15/2009 | CN101481693A Wheat salt tolerance gene TaCHP and use thereof |
07/15/2009 | CN101481692A Non-blood serum preparation of recombinant human blood coagulation factor IX |
07/15/2009 | CN101481691A Trichinella spiralis 70KDa heat shock protein and use thereof |
07/15/2009 | CN101481690A Gene engineering preparation method of anti-Candida albicans antibacterial peptide |
07/15/2009 | CN101481689A Cloning of novel sequence human insulin-like growth factor and efficient expression thereof |
07/15/2009 | CN101481688A SiRNA for inhibiting human KCTD1 gene expression and use thereof in pharmacy |
07/15/2009 | CN101481687A Anti- mycobacterium tuberculosis infection small molecule nucleotide DNA aptamer and preparation thereof |
07/15/2009 | CN101481686A Anti- mycobacterium tuberculosis infection small molecule nucleotide DNA aptamer and preparation thereof |
07/15/2009 | CN101481685A Small molecule nucleotide aptamer medicament for hepatitis C virus, preparation and use |
07/15/2009 | CN100513572C Expression system for the B subunit of cholera toxin |
07/15/2009 | CN100513571C Recombinant helicobacter pylori catalase |
07/15/2009 | CN100513570C Regulation effect of conjugated frame transport protein ABC1 |
07/15/2009 | CN100513569C Recombinant helicobacter pylori heat shock protein 60 |
07/15/2009 | CN100513568C Gene of coding recombination buman natriurea and method of producing recombination human natriurea using the gene |
07/15/2009 | CN100513567C Human SCARA5 gene, its coded protein and application |
07/15/2009 | CN100513566C Genes in gene gorup of decoupling protein 3 of pig and application thereof |
07/15/2009 | CN100513565C Apoptin-associating protein |
07/15/2009 | CN100513564C Product and process for transformation of thraustochytriales microorganisms |